Global Medical REIT Inc. (GMRE) P/E Ratio History
ExpensiveTrading at 115.3x vs 5Y avg 27.8x · 90th percentile · Material premium to history · Data 2018–2025
Loading P/E history...
P/E Ratio Analysis
As of June 20, 2026, Global Medical REIT Inc. (GMRE) trades at a price-to-earnings ratio of 115.3x, with a stock price of $35.74 and trailing twelve-month earnings per share of $-0.91.
The current P/E is 315% above its 5-year average of 27.8x. Over the past five years, GMRE's P/E has ranged from a low of 3.4x to a high of 175.0x, placing the current valuation at the 90th percentile of its historical range.
Compared to the Real Estate sector median P/E of 24.1x, GMRE trades at a 379% premium to its sector peers. The sector includes 174 companies with P/E ratios ranging from 0.7x to 195.6x.
Relative to the broader market, GMRE commands a significant premium over the S&P 500 median P/E of 24.4x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our GMRE DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
GMRE Cross-Benchmark Valuation
How does the current P/E compare to sector peers and the broader market?
GMRE P/E vs Peers
Outpatient medical offices and clinics peers sorted by market cap
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $498M | 225.2 | - | +134% | |
| $979M | 7.1Lowest | - | +1445%Best | |
| $14B | 195.6 | - | -72% | |
| $13B | 23.0 | 0.98Best | +25% | |
| $5B | 28.3 | - | +19% | |
| $2B | 14.4 | - | +24% | |
| $9B | 23.6 | 1.11 | +96% |
Lower P/E can signal a discount or weaker growth expectations; PEG adds growth context.
GMRE Historical P/E Data (2018–2025)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Period End | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2025 Q3 | - | $33.71 | $0.56 | 60.2x | +157% |
| FY2025 Q2 | Jun 30 2025 | $34.65 | $1.69 | 20.5x | -12% |
| FY2025 Q1 | Mar 31 2025 | $43.75 | $0.25 | 175.0x | +647% |
| FY2024 Q2 | Jun 30 2024 | $45.40 | $0.31 | 147.4x | +529% |
| FY2024 Q1 | Mar 31 2024 | $43.75 | $6.55 | 6.7x | -71% |
| FY2023 Q4 | Dec 31 2023 | $55.50 | $7.30 | 7.6x | -68% |
| FY2023 Q3 | Sep 30 2023 | $44.85 | $4.69 | 9.6x | -59% |
| FY2023 Q2 | Jun 30 2023 | $45.65 | $5.94 | 7.7x | -67% |
| FY2023 Q1 | Mar 31 2023 | $45.55 | $2.19 | 20.8x | -11% |
| FY2022 Q4 | Dec 31 2022 | $47.40 | $2.95 | 16.1x | -31% |
| FY2022 Q3 | Sep 30 2022 | $42.60 | $7.37 | 5.8x | -75% |
| FY2022 Q2 | - | $56.15 | $6.37 | 8.8x | -62% |
| FY2022 Q1 | - | $81.60 | $7.26 | 11.2x | -52% |
| FY2021 Q4 | Dec 31 2021 | $88.75 | $7.21 | 12.3x | -47% |
| FY2021 Q3 | - | $73.50 | $6.46 | 11.4x | -51% |
| FY2020 Q2 | - | $56.65 | $5.77 | 9.8x | -58% |
| FY2020 Q1 | - | $50.60 | $6.57 | 7.7x | -67% |
| FY2019 Q4 | - | $66.15 | $6.84 | 9.7x | -59% |
| FY2019 Q3 | Sep 30 2019 | $57.00 | $14.84 | 3.8x | -84% |
| FY2019 Q2 | Jun 30 2019 | $52.50 | $15.27 | 3.4x | -85% |
| FY2019 Q1 | Mar 31 2019 | $49.10 | $15.16 | 3.2x | -86% |
| FY2018 Q4 | Dec 31 2018 | $44.45 | $15.51 | 2.9x | -88% |
| FY2018 Q3 | Sep 30 2018 | $47.10 | $7.22 | 6.5x | -72% |
| FY2018 Q2 | Jun 30 2018 | $44.30 | $5.97 | 7.4x | -68% |
| FY2018 Q1 | Mar 31 2018 | $34.75 | $3.48 | 10.0x | -57% |
Average P/E for displayed period: 23.4x
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
8+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
GMRE — Frequently Asked Questions
Quick answers to the most common questions about buying GMRE stock.
What is GMRE's P/E ratio?
Global Medical REIT Inc. (GMRE) trailing twelve-month P/E ratio is 115.3x, based on TTM diluted EPS of $-0.91. The 5-year average P/E is 27.8x and the historical range spans 3.4x to 175.0x.
Is GMRE stock overvalued or undervalued?
GMRE trades at 115.3x P/E, above its 5-year average of 27.8x. The 90th percentile ranking within the 3.4x–175.0x historical range indicates a premium to historical valuation.
Is GMRE stock expensive?
Yes, GMRE is expensive relative to its own history. The current P/E of 115.3x is above the 5-year average of 27.8x and also above the Real Estate sector median of 24.1x. The stock sits at the 90th percentile of its 5-year valuation range.
What is GMRE's historical P/E range?
Over the past 5 years, GMRE's P/E ratio has ranged from 3.4x to 175.0x, with a median of 9.8x and an average of 27.8x. The current P/E of 115.3x places the stock at the 90th percentile of this range. Full historical data spans 2018–2025.
How does GMRE's P/E compare to the S&P 500?
GMRE trades at 115.3x P/E versus the S&P 500 median of 24.4x. The 373% premium to the market typically reflects higher expected earnings growth or quality.
How does GMRE's valuation compare to Real Estate peers?
Global Medical REIT Inc. P/E of 115.3x compares to the Real Estate sector median of 24.1x. The premium reflects expected growth above peers or stronger fundamentals. See the peer comparison table on this page for ticker-by-ticker P/E and PEG.
What is GMRE's PEG ratio?
GMRE PEG ratio is N/A, based on a P/E of 115.3x and EPS growth of -393.5%. PEG normalises P/E by growth and helps compare stocks with different earnings trajectories.
What is GMRE's earnings yield?
GMRE earnings yield is 0.87%, the inverse of its 115.3x P/E ratio. Earnings yield represents the percentage of each dollar invested that the company earns. It can be compared directly to bond yields to assess relative attractiveness of stocks versus fixed income.